265 related articles for article (PubMed ID: 22126138)
1. Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.
Izadi H; Grundy JE; Bose R
Risk Anal; 2012 May; 32(5):830-5. PubMed ID: 22126138
[TBL] [Abstract][Full Text] [Related]
2. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
Davis JA; Gift JS; Zhao QJ
Toxicol Appl Pharmacol; 2011 Jul; 254(2):181-91. PubMed ID: 21034758
[TBL] [Abstract][Full Text] [Related]
3. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
4. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
5. The current state of knowledge on the use of the benchmark dose concept in risk assessment.
Sand S; Victorin K; Filipsson AF
J Appl Toxicol; 2008 May; 28(4):405-21. PubMed ID: 17879232
[TBL] [Abstract][Full Text] [Related]
6. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
7. Use of benchmark dose and meta-analysis to determine the most sensitive endpoint for risk assessment for dimethoate.
Reiss R; Gaylor D
Regul Toxicol Pharmacol; 2005 Oct; 43(1):55-65. PubMed ID: 16099569
[TBL] [Abstract][Full Text] [Related]
8. A procedure for developing risk-based reference doses.
Gaylor DW; Kodell RL
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
[TBL] [Abstract][Full Text] [Related]
9. A benchmark dose analysis for sodium monofluoroacetate (1080) using dichotomous toxicity data.
Foronda NM; Fowles J; Smith N; Taylor M; Temple W
Regul Toxicol Pharmacol; 2007 Feb; 47(1):84-9. PubMed ID: 16965845
[TBL] [Abstract][Full Text] [Related]
10. Health assessment of phosgene: approaches for derivation of reference concentration.
Gift JS; McGaughy R; Singh DV; Sonawane B
Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
Gaylor DW; Aylward LL
Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
[TBL] [Abstract][Full Text] [Related]
12. Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment?
Brandon EF; Bulder AS; van Engelen JG; Mahieu CM; Mennes WC; Pronk ME; Rietveld AG; van de Ven BM; Ten Voorde SE; Wolterink G; Slob W; Zeilmaker MJ; Bessems JG
Regul Toxicol Pharmacol; 2013 Nov; 67(2):182-8. PubMed ID: 23871753
[TBL] [Abstract][Full Text] [Related]
13. Development of an occupational exposure limit for n-propylbromide using benchmark dose methods.
Stelljes ME; Wood RR
Regul Toxicol Pharmacol; 2004 Oct; 40(2):136-50. PubMed ID: 15450717
[TBL] [Abstract][Full Text] [Related]
14. Application of benchmark dose for occupational epidemiology in lead exposure.
Lin T; Xiao-Ting L; Ai G; Qiu-Ying L; Tai-Yi J
Toxicol Mech Methods; 2008; 18(4):363-7. PubMed ID: 20020903
[TBL] [Abstract][Full Text] [Related]
15. Benchmark dose and the three Rs. Part I. Getting more information from the same number of animals.
Slob W
Crit Rev Toxicol; 2014 Aug; 44(7):557-67. PubMed ID: 25000332
[TBL] [Abstract][Full Text] [Related]
16. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
Willhite CC; Ball GL; McLellan CJ
J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
[TBL] [Abstract][Full Text] [Related]
17. Current modeling practice may lead to falsely high benchmark dose estimates.
Ringblom J; Johanson G; Öberg M
Regul Toxicol Pharmacol; 2014 Jul; 69(2):171-7. PubMed ID: 24662478
[TBL] [Abstract][Full Text] [Related]
18. Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints.
Sand S; von Rosen D; Victorin K; Filipsson AF
Toxicol Sci; 2006 Mar; 90(1):241-51. PubMed ID: 16322076
[TBL] [Abstract][Full Text] [Related]
19. Benchmark dose approaches in chemical health risk assessment in relation to number and distress of laboratory animals.
Oberg M
Regul Toxicol Pharmacol; 2010 Dec; 58(3):451-4. PubMed ID: 20800084
[TBL] [Abstract][Full Text] [Related]
20. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
Kuljus K; von Rosen D; Sand S; Victorin K
Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]